Suggestions
Steven Huang
Psychedelics & Social Justice Advocate
Steven Huang is a prominent figure in the field of psychedelic studies and social justice. He currently serves as the Director of Social Justice at the Multidisciplinary Association for Psychedelic Studies (MAPS), where he holds the position of Justice, Equity, Diversity, and Inclusion (JEDI) Officer.1
Professional Background
Steven's career has been focused on integrating diversity, equity, and inclusion (DEI) principles into various organizations. Before joining MAPS, he held several notable positions:
- Founder of Set the Setting, a consultancy that infuses psychedelic principles into DEI approaches
- Managing Director and Head of Client Partnerships at Collective – A DEI Lab
- Head of Diversity and Inclusion at Culture Amp
Role at MAPS
At MAPS, Steven leads teams across the organization to address challenges in the psychedelic ecosystem.1 His responsibilities include:
- Designing and delivering a psychedelic-forward JEDI curriculum
- Facilitating sessions across MAPS and MAPS PBC's workforce
- Working towards making MDMA-Assisted Therapy a reality
- Addressing systemic challenges within healthcare and non-profits
- Balancing the opportunity for collective liberation while respecting indigenous history of psychedelic medicines
Expertise and Influence
Steven is recognized for his unique approach to DEI, which incorporates psychedelic principles. He frequently speaks at conferences and participates in podcasts to discuss topics such as:
- Accessible psychedelic studies2
- The intersection of psychedelics and social justice3
- Demystifying psychedelics in the context of workplace wellness4
His work aims to inspire leaders to challenge systems of oppression, implement inclusive management practices, and use privilege to create positive change.
Highlights
JUST in case I somehow end up as a Republican nominee for Vice President (or any position in office), please leak this photo to the media. Thanks in advance.
Well, at least there’s one thing Republicans and Democrats can agree on: MDMA-assisted therapy is a promising new treatment with clinically proven potential for PTSD. 61 Congress members and 19 Senators across the aisle signed letters voicing their support. Let’s hope the FDA is listening...
Some excerpts from the House letter: "In Phase three confirmatory trials, 71.2% of participants no longer qualified for a PTSD diagnosis after three eight-hour sessions of MDMA-AT. Moreover, 86.5% of participants experienced clinically significant improvements in their PTSD symptoms. These results are nearly double those of existing PTSD treatments, rendering MDMA-AT the most effective PTSD treatment ever developed. FDA has worked closely with the drug’s sponsor to design clinical trials that included strategies to ensure the study’s validity and safety, and which ultimately proved MDMA-AT’s remarkable efficacy. If the data and evidence show that MDMA-AT is safe and effective at relieving the suffering that many Veterans face, then we owe it to them and the millions of others who are living with PTSD to make this treatment option available to them."
A similar letter, co-authored by 14 veteran service organizations was published in conjunction with the congressional letters: "We are confident that if MDMA-AT can be made sufficiently accessible, it will prove to be amongst the most invaluable treatments ever developed to combat the veteran suicide epidemic."
I’m nervous as hell right now, but above all – proud to have played a supporting role in getting us this far. Bringing new treatments and ideas that can facilitate intergenerational healing is a core part of what drives my DEI practice. (Link to the House letter in the comments).
